Insilico Medicine is Trialing an AI-Backed Lung Disease DrugIn a groundbreaking development, Hong Kong researchers at biotechnology company Insilico Medicine are working on the first-ever clinical trials of a drug exclusively discovered and designed using artificial intelligence (AI). The drug, created using advanced AI algorithms, targets lung disease and aims to revolutionize treatment options. By leveraging the power of AI, scientists hope to accelerate the drug discovery process, shortening the time it takes to bring potential treatments to patients. Overall, this project hopes to make the drug discovery process more efficient and effective with the help of sophisticated tech. In addition to its lung disease drug trials, Insilico Medicine is also working on phase one clinical trials of a Covid-19 as well as cancer drugs.

Source: Economic Times July 11, 2023 16:27 UTC